UNICEF signs supply agreement for Sinopharm COVID-19 vaccine
UNICEF and Sinopharm have signed a long-term agreement for the supply of the BBIBP-CorV inactivated virus vaccine against COVID-19 on behalf of the COVAX Facility. Through the agreement, UNICEF will have access to up to 120 million doses of the vaccine by the end of 2021 to supply participating countries and territories in the COVAX Facility’s Advance Market Commitment (AMC), as…